home / stock / gild / gild articles


GILD Articles, Gilead Sciences Inc. - From 02/09/24

Stock Information

Company Name: Gilead Sciences Inc.
Stock Symbol: GILD
Market: NASDAQ
Website: gilead.com

Menu

GILD GILD Quote GILD Short GILD News GILD Articles GILD Message Board
Get GILD Alerts

News, Short Squeeze, Breakout and More Instantly...

Top 5 Health Care Stocks That Are Preparing To Pump In February | Benzinga

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, whic...

Why Gilead Sciences Stock Is Trading Lower After The Bell | Benzinga

Gilead Sciences, Inc. (NASDAQ:GILD) shares are trading lower in Tuesday’s after-hours session after the company reported weak earnings result...

Pharma Giant Gilead Raises Stake In Cancer-Focused Arcus Biosciences, Stock Soars | Benzinga

Arcus Biosciences Inc (NASDAQ:RCUS) shares are trading higher after Gilead Sciences Inc (NASDAQ:GILD) amended their collaboration ag...

Roche Walks Away From HOOKIPA Pharma-Partnered KRAS-Focused Cancer Deal | Benzinga

HOOKIPA Pharma Inc (NASDAQ:HOOK) will focus its resources on prioritizing the clinical development of a randomized trial for its HB-200 progra...

Gilead's Tecartus Dropped From FDA List Of CAR-T Therapy With Updated Label Warning Of "Risks Of Secondary Cancer' | Benzinga

Tuesday, the FDA announced to impose a classwide black box warning following its investigation into secondary T-cell cancers arising from the ...

If You Invested $100 In This Stock 20 Years Ago, You Would Have $1,000 Today | Benzinga

Gilead Sciences (NASDAQ:GILD) has outperformed the market over the past 20 years by 5.49% on an annualized basis producing an average annual return...

Focus On Bristol Myers, Gilead Sciences, Johnson & Johnson, Novartis: FDA To Issue Classwide Black Box Warning on CAR-T Therapies For Blood Cancer Treatment | Benzinga

In a significant development, the FDA is set to impose a classwide black box warning following its investigation into secondary T-cell ca...

Dow Gains Over 100 Points; Archer-Daniels-Midland Shares Plunge | Benzinga

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Monday. The Dow traded up 0.27% to 37...

Why CommScope Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Monday's Mid-Day Session | Benzinga

Shares of CommScope Holding Company, Inc. (NASDAQ: COMM) fell sharply during Monday’s session. B of A Securities analyst Tal Liani downgraded...

Crude Oil Surges Over 2%; US Leading Economic Index Falls In December | Benzinga

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 150 points on Monday. The Dow traded up 0.41% to 38,018.2...

Previous 10 Next 10